REFERENCE: 1. IQVIA. National Prescription Audit Report. December 2019.
As a specialty pharmaceutical company, Sebela Pharmaceuticals is a market leader in gastroenterology, dermatology and women’s health. We have the #1 prescribed branded bowel prep kit, the #1 prescribed brand for interdigital tinea pedis, and the #1 prescribed branded hemorrhoid treatment by gastroenterologists and colorectal surgeons.1
Sebela Pharmaceuticals is optimally positioned for continued growth organically and through acquisitions, in-licensing and partnering. We are focused on:
At Sebela Pharmaceuticals, we are focused on specialty therapies that can be effectively marketed through a targeted sales force. In addition to growing the products within our existing portfolio, we are actively looking to acquire or in-license commercialized and late-stage development products in the following categories:
To discuss commercial or business development opportunities, please contact us using the form below:
REFERENCE: 1. IQVIA. National Prescription Audit Report. December 2019.